The Wistar Institute: Wistar Research Identifies Mechanisms for Selective Multiple Sclerosis Treatment Strategy
Wistar's Lieberman lab stopped inflammatory signaling and immune response in lab samplesPHILADELPHIA, PA, May 28, 2024., and lab team led by senior staff scientist and first author, Samantha Soldan, Ph.D.